Novel radiolabeled ligand, Para-chloro-2-[<sup>18</sup>F]fluoroethyletomidate (CETO) compared to [<sup>11</sup>C]metomidate-PET (MTO) for the lateralisation of primary aldosteronism (PA)
Emily Goodchild(St Bartholomew's Hospital), Morris J. Brown(Queen Mary University of London), Samuel O’Toole(Royal Hallamshire Hospital), Victoria Warnes(Cambridge University Hospitals NHS Foundation Trust), James MacFarlane(University of Cambridge), Kate Laycock(St Bartholomew's Hospital), Jackie Salsbury(Queen Mary University of London), Russell Senanayake(University of Cambridge), Dan Gillett, Giulia Argentesi(St Bartholomew's Hospital), Waiel Bashari(University of Cambridge), Franklin I. Aigbirhio(University of Cambridge), Mark Gurnell(University of Cambridge), Xi‐Lin Wu(Queen Mary University of London), Stefan Hader(University of Cambridge), William Drake, Kennedy Cruickshank, Nicholas J. Bird(Cambridge University Hospitals NHS Foundation Trust), Anju Sadhev, Heok Cheow(Cambridge University Hospitals NHS Foundation Trust), István Boros(University of Cambridge)
Cited by 1
Related Papers
Traumatic brain injury: progress and challenges in prevention, clinical care, and research
|The Lancet Neurology|2022|1.3k
Mapping neurotransmitter systems to the structural and functional organization of the human neocortex
|Nature Neuroscience|2022|773